A Non-interventional, Prospective Study With Benralizumab

ChAracterisation of ItaliaN Severe Uncontrolled Asthmatic patieNts Key Features When Receiving Benralizumab

NCT04272463 ·Status: COMPLETED

Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma

NCT02322775 ·Status: COMPLETED ·Phase: PHASE3

Patient-Reported OUTcomes of Benralizumab in Real-World Use in Severe EosiNophilic Asthma Patients

NCT05603845 ·Status: COMPLETED

Patient Reported Outcomes in Adults With Severe Eosinophilic Asthma on Benralizumab.

NCT03833141 ·Status: COMPLETED

Benralizumab Exacerbation Study

NCT04102800 ·Status: COMPLETED ·Phase: PHASE4

STEP: Phase IIIb Study of Benralizumab to Step-down Maintenance Therapy in Patients With Severe Eosinophilic Asthma

NCT06465485 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Observational Retrospective Study on Clinical Outcomes of Patients Receiving Benralizumab in Spain.

NCT04648839 ·Status: COMPLETED

Study to Evaluate the Effect of Benralizumab on Allergen-Induced Inflammation in Mild, Atopic Asthmatics

NCT02821416 ·Status: COMPLETED ·Phase: PHASE3

Real World Study With Benralizumab in Severe Asthma in Switzerland

NCT03907137 ·Status: COMPLETED

Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics

NCT03953300 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Patients With Severe Eosinophilic Asthma Treated With Benralizumab

NCT05078281 ·Status: UNKNOWN

Evaluating the Effect of Benralizumab in Severe, Poorly-controlled Eosinophilic Asthma Using Inhaled Hyperpolarized 129-Xenon MRI

NCT03733535 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy

NCT07214753 ·Status: RECRUITING

Study to Characterise Patients Receiving Benralizumab in the Framework of an Individualized Access Program in Spain

NCT04126499 ·Status: COMPLETED

BenRalizumab Effect on Airway Remodeling in Severe asTHma

NCT06288516 ·Status: RECRUITING ·Phase: PHASE4

Pharmacokinetic Comparability of Benralizumab Using Accessorized Pre-Filled Syringe or Autoinjector in Healthy Volunteers

NCT02968914 ·Status: COMPLETED ·Phase: PHASE1

Benralizumab in Patients With Inadequate Response to Anti-IL5 Monoclonal Antibody Therapies

NCT03470311 ·Status: COMPLETED ·Phase: PHASE3

Descriptive Study of the Incidence of Malignancy in Severe Asthma Patients Receiving Benralizumab and Other Biologic Therapy, a Post Authorization Safety Study

NCT04991805 ·Status: COMPLETED

Study to Assess Functionality, Reliability, and Performance of a Pre-filled Syringe With Benralizumab Administered at Home

NCT02417961 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of Benralizumab to Reduce OCS Use in Patients With Uncontrolled Asthma on High Dose Inhaled Corticosteroid Plus LABA and Chronic OCS Therapy

NCT02075255 ·Status: COMPLETED ·Phase: PHASE3

Effect of Benralizumab on Airway Remodeling in Asthma

NCT04365205 ·Status: RECRUITING

Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma

NCT01947946 ·Status: TERMINATED ·Phase: PHASE3

The Effect of Benralizumab on Exercise-induced Bronchoconstriction

NCT03327701 ·Status: UNKNOWN ·Phase: PHASE3

An Observational Prospective Study to Characterize Patients Initiating Enerzair® Breezhaler®, With or Without Sensor, as a Maintenance Treatment for Asthma

NCT05120986 ·Status: WITHDRAWN

Real-life First Dose Effect of Fasenra in Patients With Severe Uncontrolled Asthma

NCT04200326 ·Status: COMPLETED